Concordare Trials Raises Funding Round

Concordare Trials, based in New York, is an AI-powered platform that converts static clinical trial protocol PDFs into a structured, interoperable digital format. The company recently closed a funding round to support its efforts in accelerating the digitization of clinical trial protocols.

Investors

This round was led by Surface Ventures, with participation from Techstars, Innovation Works, Gaingels, and several individual investors.

Concordare Trials Use of Funds

The company plans to use the capital to support product development, expand its team, and grow its site partnership network.

About Concordare Trials

Founded by Zach Sawaged, Concordare Trials focused on digitizing clinical trial protocols and reducing the manual work involved in configuring clinical studies across different systems. Its flagship Concordare Suite uses AI to extract information from clinical trial protocol PDFs and convert it into a structured, interoperable Clinical Trial Protocol Model (CTPM).

Funding Details

Company Website: https://concordare.com

Company: Concordare Trials
Round: Other
Funding Date: August 25, 2026
Lead Investor: Surface Ventures
Additional Investors: Techstars, Innovation Works, Gaingels, individual investors
Company Website: https://concordare.com/
Software Category: HealthTech
Source: https://www.businesswire.com/news/home/20260825901105/en/Concordare-Trials-Secures-Funding-Round-to-Accelerate-Digitization-of-Clinical-Trial-Protocols